PhaseBio Pharmaceuticals, Inc. (PHAS) News

PhaseBio Pharmaceuticals, Inc. (PHAS): $0.07

0.02 (-26.21%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add PHAS to Watchlist
Sign Up

Filter PHAS News Items

PHAS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!